현대바이오랜드
Financials
Valuation Metrics
현대바이오랜드's Market Cap is ₩1190B. At end of 2025 it was ₩1289B. Ranked #1172 of 2,421 in KR market (top 48%), #624 of 1,640 on KOSDAQ (top 38%), #27 of 57 in Household & Personal Products (top 47%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 118.95B KRW | KR#1,172/2,421 Sec#27/57 |
| Revenue | 140.70B KRW | KR#1,224/2,421 Sec#27/57 |
| Net Income | 13.35B KRW | KR#866/2,421 Sec#21/57 |
| Total Assets | 166.29B KRW | KR#1,435/2,421 Sec#27/57 |
| Net Assets | 145.56B KRW | KR#1,158/2,421 Sec#21/57 |
| Employees | 347 | KR#694/2,421 Sec#15/57 |
| Value | ||
| P/E | 8.91x | KR#728/2,421 Sec#11/57 |
| P/B | 0.82x | KR#1,284/2,421 Sec#26/57 |
| P/S | 0.85x | KR#1,273/2,421 Sec#28/57 |
| EV/EBITDA | 8.02x | KR#478/2,421 Sec#8/57 |
| FCF Yield | 13.01% | KR#498/2,421 Sec#4/57 |
| Profitability | ||
| ROE | 9.17% | KR#684/2,421 Sec#20/57 |
| ROA | 8.03% | KR#438/2,421 Sec#16/57 |
| Op. Margin | 10.29% | KR#506/2,421 Sec#13/57 |
| Revenue Growth | 14.11% | KR#720/2,421 Sec#19/57 |
| Financial Health | ||
| Debt Ratio | 14.24% | KR#231/2,421 Sec#7/57 |
| Total Debt | 6.00B KRW | KR#1,754/2,421 Sec#40/57 |
| FCF | 15.48B KRW | KR#588/2,421 Sec#14/57 |
| Cash | 8.89B KRW | KR#1,759/2,421 Sec#34/57 |
| Current Ratio | 5.06x | KR#282/2,421 Sec#5/57 |
| Net Debt/EBITDA | -0.20x | KR#570/2,421 Sec#17/57 |
| Dividend | ||
| Div. Yield | 1.77% | KR#929/2,421 Sec#21/57 |
| Div. Growth | 0.00% | KR—/2,421 Sec—/57 |
| Performance | ||
| 1Y Return | -18.58% | KR#1,230/2,421 Sec#26/57 |
| 1M Return | 1.54% | KR#1,070/2,421 Sec#20/57 |
| From 52W High | -25.47% | KR#392/2,421 Sec#13/57 |
| 1Y MDD | -38.34% | KR#525/2,421 Sec#13/57 |
| Trading | ||
| Volume | 55,899 shares | KR#1,076/2,421 Sec#26/57 |
| Trading Value | 224.3M KRW | KR#1,227/2,421 Sec#30/57 |
| Foreign Own. | 2.82% | KR#1,349/2,421 Sec#25/57 |
| Per Share | ||
| EPS | 445 KRW | KR#1,039/2,421 Sec#28/57 |
| BPS | 4,852 KRW | KR#1,515/2,421 Sec#33/57 |
Company Info
Hyundaibioland was established in 1995 to manufacture and sell natural product cosmetic and functional food ingredients, listing on KOSDAQ in 2001. The company operates in cosmetic ingredients, health functional foods, pharmaceutical ingredients, medical devices, and brand distribution, leveraging natural-derived biomaterials. It focuses on discovering natural materials and R&D to enhance global competitiveness and develop next-generation Big Items through convergence technology, in response to stricter environmental regulations. Hyundaibioland is headquartered in Cheongju-si, Chungcheongbuk-do.